Gradual incorporation of information: Pharmaceutical stocks and the evolution of president Clinton's health care reform

Journal of Law and Economics

Volumn 44, Issue 1, 2001, Pages 89-129

  Ellison, Sara Fisher ^a   Mullin, Wallace P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041027253     PISSN: 00222186     EISSN: None     Source Type: Journal    
DOI: 10.1086/320269     Document Type: Article

References (35)

1. Aaron, Henry J. "The Problem That Won't Go Away." In The Problem That Won't Go Away: Reforming U.S. Health Care Financing, edited by Henry J. Aaron, pp. 1-12. Washington, D.C.: Brookings Institution, 1996.
2. Ball, Clifford A., and Torous, Walter N. "Investigating Security-Price Performance in the Presence of Event-Date Uncertainty." Journal of Financial Economics 22 (1988): 123-53.
3. Barlow, Richard E., et al. Statistical Inference under Order Restrictions. New York: John Wiley and Sons, 1972.
4. Bizjak, John M., and Coles, Jeffrey L. "The Effect of Private Antitrust Litigation on the Stock-Market Valuation of the Firm." American Economic Review 85 (1995): 436-61.
5. Brown, Stephen J., and Warner, Jerold B. "Measuring Security Price Performance." Journal of Financial Economics 8 (1980): 205-58.
6. Brunk, H. D. "Estimation of Isotonic Regression." In Nonparametric Techniques in Statistical Inference, edited by M. L. Puri, pp. 177-95. Cambridge: Cambridge University Press, 1970.
7. Campbell, John Y.; Lo, Andrew W.; and MacKinlay, A. Craig. The Econometrics of Financial Markets. Princeton, N.J.: Princeton University Press, 1997.
8. Chernoff, Herman. "Estimation of the Mode." Annals of the Institute of Statistics and Mathematics 16 (1964): 31-41.
9. Cutler, David M. "Tax Reform and the Stock Market: An Asset Price Approach." American Economic Review 78 (1988): 1107-17.
10. Cutler, David M.; Poterba, James M.; and Summers, Lawrence H. "What Moves Stock Prices?" Journal of Portfolio Management 15 (1989): 4-12.
11. Ellison, Sara Fisher. "What Prices Can Tell Us about the Market for Antibiotics." Unpublished manuscript. Cambridge: Massachusetts Institute of Technology, 1998.
12. Ellison, Sara Fisher, and Mullin, Wallace P. "Economics and Politics: The Case of Sugar Tariff Reform." Journal of Law and Economics 38 (1995): 335-66.
13. Ellison, Sara Fisher, and Wolfram, Catherine. "Pharmaceutical Prices and Political Activity." Unpublished manuscript. Cambridge: Massachusetts Institute of Technology and Harvard University, April 2000.
14. Fidelity Investments Prospectus, Fidelity Select Portfolios, April 29, 1999, p. P-19.
15. Fuchs, Victor R. "The Future of Health Economics." Journal of Health Economics 19 (2000): 141-57.
16. Grossman, Gene M., and Levinsohn, James A. "Import Competition and the Stock Market Return to Capital." American Economic Review 79 (1989): 1065-87.
17. Hausman, J. A.; Abrevaya, Jason; and Scott-Morton, F. M. "Misclassification of the Dependent Variable in a Discrete-Response Setting." Journal of Econometrics 87 (1998): 239-269.
18. Johnson, Haynes, and Broder, David. The System: The American Way of Politics at the Breaking Point. New York: Little, Brown & Company, 1997.
19. Leurgans, Sue. "Asymptotic Distributions of Slope-of-Greatest-Convex-Minorant Estimators." Annals of Statistics 10 (1982): 287-96.
20. MacKinlay, A. Craig. "Event Studies in Economics and Finance." Journal of Economic Literature 35 (1997): 13-39.
21. Malatesta, Paul H. "The Wealth Effect of Merger Activity and the Objective Functions of Merging Firms." Journal of Financial Economics 11 (1983): 155-81.
22. Malatesta, Paul H., and Thompson, Rex. "Partially Anticipated Events." Journal of Financial Economics 14 (1985): 237-50.
23. Mitchell, Mark L., and Stafford, Erik. "Managerial Decisions and Long-Term Stock Price Performance." Unpublished manuscript. Chicago: University of Chicago, 1997.
24. Pakes, Ariel. "On Patents, R&D, and the Stock Market Rate of Return." Journal of Political Economy 93 (1985): 390-409.
25. Rose, Nancy L. "The Incidence of Regulatory Rents in the Motor Carrier Industry." Rand Journal of Economics 16 (1985): 299-318.
26. Salinger, Michael. "Standard Errors in Event Studies." Journal of Financial and Quantitative Analysis 27 (1992): 39-53.
27. Salinger, Michael. "Value Event Studies." Review of Economics and Statistics 74 (1992): 671-77.
28. Salinger, Michael. "When Do Peeping Toms See Something (Statistically) Significant?" Unpublished manuscript. Boston: Boston University School of Management, 1994.
29. Schweitzer, Stuart O. Pharmaceutical Economics and Policy. New York: Oxford University Press, 1997.
30. Schwert, G. William. "Using Financial Data to Measure Effects of Regulation." Journal of Law and Economics 24 (1981): 121-58.
31. Thomas, Lacy Glenn. "Industrial Policy and International Competitiveness in the Pharmaceutical Industry." In Competitive Strategies in the Pharmaceutical Industry, edited by Robert B. Helms, pp. 107-29. Washington, D.C.: American Enterprise Institute Press, 1996.
32. Weisbrod, Burton A. "The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment." Journal of Economic Literature 29 (1991): 523-52.
33. Willard, Kristen L.; Guinnane, Timothy W.; and Rosen, Harvey S. "Turning Points in the Civil War: Views from the Greenback Market." American Economic Review 86 (1996): 1001-18.
34. White House Domestic Policy Council. The President's Health Security Plan. New York: Times Books, 1993.
35. Wright, F. T. "The Asymptotic Behavior of Monotone Regression Estimates." Annals of Statistics 9 (1981): 443-48.